$AGEN
AGENUS INC

2016 Q1 Form 10-K Financial Statement

#000156459016014840 Filed on March 15, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 2014 Q4
Revenue $5.959M $24.82M $1.619M
YoY Change 50.75% 255.67% 311.96%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $24.80M $1.620M
YoY Change 255.43% 315.38%
Gross Profit Margin 99.93% 100.06%
Selling, General & Admin $9.230M $28.40M $5.040M
YoY Change 68.12% 33.96% 49.55%
% of Gross Profit 114.52% 311.11%
Research & Development $25.04M $70.44M $7.370M
YoY Change 171.56% 215.2% 127.47%
% of Gross Profit 284.05% 454.94%
Depreciation & Amortization $1.240M $1.400M $560.0K
YoY Change 175.56% 27.27% 300.0%
% of Gross Profit 5.65% 34.57%
Operating Expenses $25.04M $70.44M $18.94M
YoY Change 171.56% 215.2% 186.54%
Operating Profit -$27.97M -$80.70M -$17.32M
YoY Change 52.91% 86.29% 178.46%
Interest Expense -$4.132M -$6.599M -$300.0K
YoY Change -1141.28% -623.06% -14.29%
% of Operating Profit
Other Income/Expense, Net $323.1K -$5.968M -$8.350M
YoY Change -710.22% -384.7% -1143.75%
Pretax Income -$31.78M -$93.27M -$25.98M
YoY Change 69.58% 119.53% 349.48%
Income Tax -$5.387M
% Of Pretax Income
Net Earnings -$31.78M -$87.88M -$25.98M
YoY Change 69.57% 106.85% 349.68%
Net Earnings / Revenue -533.29% -354.12% -1604.57%
Basic Earnings Per Share
Diluted Earnings Per Share -$366.6K -$1.124M -$413.2K
COMMON SHARES
Basic Shares Outstanding 86.52M 62.68M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $148.2M $171.7M $40.20M
YoY Change 86.89% 327.11% 46.72%
Cash & Equivalents $78.33M $136.7M $25.71M
Short-Term Investments $69.90M $35.00M $14.50M
Other Short-Term Assets $3.100M $2.600M $640.0K
YoY Change 314.75% 13.04% 292.62%
Inventory $100.0K $100.0K $95.70K
Prepaid Expenses $1.248M
Receivables $10.20M $9.800M $463.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $161.6M $184.1M $42.67M
YoY Change 89.77% 331.15% 51.45%
LONG-TERM ASSETS
Property, Plant & Equipment $16.60M $15.30M $5.997M
YoY Change 182.33% 155.0% 115.33%
Goodwill $17.87M
YoY Change 594.7%
Intangibles $6.774M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.300M $1.300M $1.217M
YoY Change 7.71% 8.33% -6.68%
Total Long-Term Assets $59.50M $58.10M $31.86M
YoY Change 84.95% 82.7% 378.26%
TOTAL ASSETS
Total Short-Term Assets $161.6M $184.1M $42.67M
Total Long-Term Assets $59.50M $58.10M $31.86M
Total Assets $221.1M $242.2M $74.53M
YoY Change 88.45% 225.1% 113.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.500M $4.500M $1.711M
YoY Change -37.07% 164.71% 104.97%
Accrued Expenses $19.90M $14.20M $5.502M
YoY Change 218.2% 158.18% 30.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $1.257M
YoY Change -76.41% -92.31% -64.27%
Total Short-Term Liabilities $31.30M $28.90M $9.229M
YoY Change 49.05% 214.13% -10.36%
LONG-TERM LIABILITIES
Long-Term Debt $118.2M $114.3M $4.769M
YoY Change 964.86% 2281.25% -10.01%
Other Long-Term Liabilities $27.30M $28.20M $2.800M
YoY Change 814.27% -24.8% 66.73%
Total Long-Term Liabilities $145.5M $142.5M $7.570M
YoY Change 4772.73% 236.88% 350.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.30M $28.90M $9.229M
Total Long-Term Liabilities $145.5M $142.5M $7.570M
Total Liabilities $176.7M $171.5M $16.80M
YoY Change 636.71% 233.01% 40.28%
SHAREHOLDERS EQUITY
Retained Earnings -$691.3M
YoY Change 6.5%
Common Stock $627.2K
YoY Change 72.35%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change -100.0%
Treasury Stock Shares 0.000 shares
Shareholders Equity $44.50M $70.70M $23.02M
YoY Change
Total Liabilities & Shareholders Equity $221.1M $242.2M $74.53M
YoY Change 88.45% 225.1% 113.94%

Cashflow Statement

Concept 2016 Q1 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$31.78M -$87.88M -$25.98M
YoY Change 69.57% 106.85% 349.68%
Depreciation, Depletion And Amortization $1.240M $1.400M $560.0K
YoY Change 175.56% 27.27% 300.0%
Cash From Operating Activities -$21.53M -$47.18M -$10.50M
YoY Change -753.35% 23.4% 89.53%
INVESTING ACTIVITIES
Capital Expenditures $1.537M $3.591M -$1.710M
YoY Change 375.02% 27.36% 2750.0%
Acquisitions $7.182M
YoY Change
Other Investing Activities -$34.92M -$27.64M $10.00K
YoY Change -340.33% 97.57%
Cash From Investing Activities -$36.46M -$31.23M -$1.700M
YoY Change -356.56% 85.75% 2733.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -560.0K 189.6M -730.0K
YoY Change -101.55% 258.98% -126.45%
NET CHANGE
Cash From Operating Activities -21.53M -47.18M -10.50M
Cash From Investing Activities -36.46M -31.23M -1.700M
Cash From Financing Activities -560.0K 189.6M -730.0K
Net Change In Cash -58.55M 111.2M -12.93M
YoY Change -209.23% -5069.66% 355.28%
FREE CASH FLOW
Cash From Operating Activities -$21.53M -$47.18M -$10.50M
Capital Expenditures $1.537M $3.591M -$1.710M
Free Cash Flow -$23.07M -$50.77M -$8.790M
YoY Change -876.2% 23.67% 60.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
463007
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1247548
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
639957
CY2014Q4 us-gaap Assets Current
AssetsCurrent
42670301
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5996687
CY2014Q4 us-gaap Goodwill
Goodwill
17869023
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6773722
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1216795
CY2014Q4 us-gaap Assets
Assets
74526528
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1257178
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Entity Registrant Name
EntityRegistrantName
AGENUS INC
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001098972
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q4 us-gaap Inventory Net
InventoryNet
95700
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
14509570
CY2013 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2419798
CY2015Q4 us-gaap Assets Current
AssetsCurrent
184095366
CY2015 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
495742
CY2015Q2 dei Entity Public Float
EntityPublicFloat
571000000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15310623
CY2014Q4 agen Contingent Royalty
ContingentRoyalty
15279000
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
536118
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1690
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-88166804
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44660426
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33232451
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-17600157
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16990316
CY2013 agen Stock Issued During Period For Extinguishment Of Debt
StockIssuedDuringPeriodForExtinguishmentOfDebt
12416689
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4054561
CY2013 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
4347
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15130
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
88880
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-4480703
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
600659
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4604713
CY2014 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
487227
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
119774
CY2014 agen Shares Issued To Repurchase Convertible Senior Notes Value
SharesIssuedToRepurchaseConvertibleSeniorNotesValue
953765
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
145314
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
106597
CY2014 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
460963
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8098650
CY2015 agen Stock Issued Under Stock Purchase Agreement Value
StockIssuedUnderStockPurchaseAgreementValue
35000001
CY2015 agen Issuance Of Shares Related To Milestone Achievement Value
IssuanceOfSharesRelatedToMilestoneAchievementValue
344541
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3038438
CY2015 agen Issuance Of Stock For Settlement Of Contingent Royalty Obligation Value
IssuanceOfStockForSettlementOfContingentRoyaltyObligationValue
2142000
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
86516484
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
136702873
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25714519
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
34964730
CY2015Q4 us-gaap Inventory Net
InventoryNet
88200
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9800342
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1956941
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
582280
CY2015 us-gaap Dividends Preferred Stock
DividendsPreferredStock
202960
CY2014 us-gaap Dividends Preferred Stock
DividendsPreferredStock
203832
CY2013 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3159782
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33232451
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5501527
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6304281
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
575351
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28934090
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9229423
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4488561
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1710946
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14165816
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
114326489
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
16420300
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2800491
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74526528
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29488793
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28369982
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
987394
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
462248
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86390697
CY2014 us-gaap Revenue From Grants
RevenueFromGrants
504228
CY2015 us-gaap Revenue From Grants
RevenueFromGrants
24118
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21249710
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28370001
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-6703700
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62720065
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
184421
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13005366
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-6699300
CY2014 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
6473227
CY2013 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
1627343
CY2014 us-gaap Revenues
Revenues
6977455
CY2013 us-gaap Revenues
Revenues
3045207
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70444259
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22349327
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4769359
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3009568
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5608000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7566601
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
863907
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
627201
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
851103934
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
715667633
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2053143
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1970420
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-779187464
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-691306343
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
70727550
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
23018387
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242228484
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
74669980
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14483835
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-24980112
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42690006
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2096334
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-43320882
CY2015Q4 us-gaap Goodwill
Goodwill
22792778
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18759662
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59753552
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1766861
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2672759
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-30072669
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-42486174
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29765547
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.12
CY2014 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1261626
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-30072669
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-42486174
CY2014 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1778184
CY2015 agen Research And Development Revenue
ResearchAndDevelopmentRevenue
24792907
CY2015 us-gaap Revenues
Revenues
24817025
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1270055
CY2015Q4 us-gaap Assets
Assets
242228484
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
146061
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3829371
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
15065754
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
164150
CY2013 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1417864
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-93268188
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5387067
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78212094
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1764
CY2015 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
245183
CY2014 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
194000
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
56792252
CY2015 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
105245
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.13
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-88084081
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-87881121
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5968170
CY2015 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6599083
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-82723
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-80700936
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1970420
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1583960
CY2014 agen Non Cash Interest Expense
NonCashInterestExpense
619846
CY2013 agen Non Cash Interest Expense
NonCashInterestExpense
1820787
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4583
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-59110
CY2015 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
13567000
CY2014 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
3579159
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3322657
CY2015 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
1522377
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
7438308
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
4672256
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
4127786
CY2015 agen Non Cash Interest Expense
NonCashInterestExpense
5626918
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5387067
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9331622
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-31232018
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2015 us-gaap Depreciation
Depreciation
1400000
CY2014 us-gaap Depreciation
Depreciation
1100000
CY2013 us-gaap Depreciation
Depreciation
586000
CY2014Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6257000
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
109669980
CY2015 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1975139
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
208278
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1957591
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
586343
CY2015 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
12245231
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-154117
CY2013 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
355500
CY2014 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
201092
CY2013 agen Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
291517
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1200
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-551134
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7500
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
95700
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16022
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
703424
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
254045
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
112505
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2668064
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-45902
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
189638
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
15957820
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3610811
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1474171
CY2015 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
9565639
CY2014 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1316169
CY2013 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1916467
CY2015 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
11538019
CY2014 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
685696
CY2013 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-183473
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-47175441
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-38234585
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-19532945
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7182069
CY2014 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
514470
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3591335
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2819764
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
813520
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
34993100
CY2014 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
14507806
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
14534486
CY2013 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
450000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16813100
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-363520
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
26462810
CY2014 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
251911
CY2013 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
104010
CY2014 agen Financing Of Plant And Equipment
FinancingOfPlantAndEquipment
39156
CY2013 agen Financing Of Plant And Equipment
FinancingOfPlantAndEquipment
53297
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
109000000
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
10000000
CY2015 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1774323
CY2013 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
177802
CY2015 us-gaap Repayments Of Debt
RepaymentsOfDebt
1111111
CY2014 us-gaap Repayments Of Debt
RepaymentsOfDebt
3333334
CY2013 us-gaap Repayments Of Debt
RepaymentsOfDebt
555556
CY2015 agen Payments Of Contingent Purchase Price Consideration
PaymentsOfContingentPurchasePriceConsideration
8180000
CY2014 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
460963
CY2015 agen Payment Of Contingent Purchase Price Obligation
PaymentOfContingentPurchasePriceObligation
20000000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
52810710
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25780165
CY2014 agen Payment Of Contingent Purchase Price Obligation
PaymentOfContingentPurchasePriceObligation
400000
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
10000000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
189579685
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-183873
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
599525
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
110988354
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1637450
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5883700
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27351969
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21468269
CY2015 us-gaap Interest Paid
InterestPaid
1053447
CY2014 us-gaap Interest Paid
InterestPaid
675391
CY2013 us-gaap Interest Paid
InterestPaid
579650
CY2014 agen Business Combination Contingent Consideration Initial Issue
BusinessCombinationContingentConsiderationInitialIssue
9721000
CY2013 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
2906664
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
953765
CY2013 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
11275000
CY2013 agen Conversion Of Notes Payable To Future Royalties
ConversionOfNotesPayableToFutureRoyalties
19090658
CY2013 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
5580124
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;text-indent:2.27%;">(c) Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base those estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p></div>
CY2015Q3 us-gaap Debt Issuance Costs
DebtIssuanceCosts
1500000
CY2014Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
3334079
CY2014Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
10100000
CY2014 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
7183000
CY2013 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
6949000
CY2014 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-43282000
CY2015Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
114146000
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-866000
CY2014 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-773000
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2015Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
171700000
CY2015 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2013 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-39065000
CY2014 agen Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-0.72
CY2013 agen Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-1.18
CY2015Q4 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
2500000
CY2015Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
1631521
CY2015Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
7400000
CY2015 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
4936000
CY2015 us-gaap Goodwill Other Changes
GoodwillOtherChanges
-12000
CY2015Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
19747000
CY2014 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
1901000
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7236000
CY2015 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P9Y
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
525000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
462000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2200000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2200000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2100000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1900000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1900000
CY2014 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0
CY2015 agen Available For Sale Securities Sold Before Maturity
AvailableForSaleSecuritiesSoldBeforeMaturity
0
CY2015Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
126400000
CY2014Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
25100000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
44800000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34367000
CY2015Q4 agen Deferred Tax Assets Operating Loss Carry Forwards Federal And State
DeferredTaxAssetsOperatingLossCarryForwardsFederalAndState
221139000
CY2014Q4 agen Deferred Tax Assets Operating Loss Carry Forwards Federal And State
DeferredTaxAssetsOperatingLossCarryForwardsFederalAndState
192223000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
8412000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
10153000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
19475000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
14393000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10339000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8327000
CY2014Q4 agen Deferred Tax Assets Contingent Consideration
DeferredTaxAssetsContingentConsideration
3370000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7123000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6732000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
266488000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
235198000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
260057000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
234149000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6431000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1049000
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7093000
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1471000
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
662000
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
422000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-31669000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14445000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10225000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
25908000
CY2015 agen Shares Issued For Contingent Milestone Payment Value
SharesIssuedForContingentMilestonePaymentValue
345000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
14043000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
9561000
CY2015 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
203000
CY2014 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
117000
CY2013 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
102000
CY2015 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-3869000
CY2014 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-642000
CY2013 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-1359000
CY2014 agen Net Operating Loss Expirations
NetOperatingLossExpirations
996000
CY2013 agen Net Operating Loss Expirations
NetOperatingLossExpirations
1778000
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-314000
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
726000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
4354000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-795000
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
143000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5778000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
203000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
500000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5481000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4600000
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
3134000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3343000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1438000
CY2015Q4 agen Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
3886000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2336000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
930000
CY2015Q4 agen Current Portion Purchase Price
CurrentPortionPurchasePrice
5906000
CY2015Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
398000
CY2014Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
575000
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2003Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
666666
CY2007Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
270562
CY2007Q3 agen Stock Issued During Period Price Per Share
StockIssuedDuringPeriodPricePerShare
18.48
CY2008Q1 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
1451450
CY2008Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.00
CY2008Q1 agen Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
P10Y
CY2008Q1 agen Class Of Warrant Or Right Exercisable Term
ClassOfWarrantOrRightExercisableTerm
P9Y6M
CY2008Q1 agen Warrants Issued
WarrantsIssued
1451450
CY2008Q2 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
1166666
CY2008Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
18.00
CY2009Q3 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
833333
CY2009Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12.00
CY2009Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000
CY2009Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
778982
CY2009Q3 agen Shares Issued In Private Placements Shares
SharesIssuedInPrivatePlacementsShares
730994
CY2009Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
13.68
CY2009Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000
CY2009Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
694441
CY2014Q4 agen Aggregate Gross Proceeds Available
AggregateGrossProceedsAvailable
150000000
CY2015 agen Shares Issued For Contingent Milestone Payment
SharesIssuedForContingentMilestonePayment
80493
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
12650000
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
75000000
CY2015Q4 agen Weighted Average Stock Price Of Shares Credited Under Director Deferred Compensation Plan
WeightedAverageStockPriceOfSharesCreditedUnderDirectorDeferredCompensationPlan
5.68
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.77
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.84
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.87
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6525724
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2822944
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
462428
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
407032
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
133373
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8345835
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7649324
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
4436522
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.40
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.82
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.82
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.75
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.87
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.77
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.80
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.97
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M9D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y3M11D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5580689
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5065702
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2998504
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.55
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.87
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.42
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
45000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5000
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
78828
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1747789
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
35332
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
60681
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1730604
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.93
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.64
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
3.97
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
7.91
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
8.55
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
140000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
205000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
1600000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7438000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4672000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4128000
CY2015Q4 agen Estimate Of Payments For Clinical Trials
EstimateOfPaymentsForClinicalTrials
78000000
CY2015 agen Clinical Trials Expense
ClinicalTrialsExpense
19900000
CY2014 agen Clinical Trials Expense
ClinicalTrialsExpense
895000
CY2013 agen Clinical Trials Expense
ClinicalTrialsExpense
2700000
CY2014Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
14510000
CY2014Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
31699000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3296000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3171000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3040000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2566000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
7893000
CY2015Q4 agen Cumulative Payments For Clinical Trials
CumulativePaymentsForClinicalTrials
65000000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2300000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2100000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3315000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
23281000
CY2015Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1000000
CY2015 agen Amounts Drawn On Letter Of Credit
AmountsDrawnOnLetterOfCredit
0
CY2015Q4 us-gaap Security Deposit
SecurityDeposit
270000
CY2015 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
780000
CY2014 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
365000
CY2013 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
481000
CY2014Q4 agen Long Term Debt Current Principal Amount
LongTermDebtCurrentPrincipalAmount
1257000
CY2015Q4 agen Long Term Debt Noncurrent Principal Amount
LongTermDebtNoncurrentPrincipalAmount
114000000
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
4342000
CY2015Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1481000
CY2015Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2535000
CY2015 agen Interest Expense Debt Non Operating
InterestExpenseDebtNonOperating
4342000
CY2015Q4 agen Unamortized Debt Issuance Expense Long Term
UnamortizedDebtIssuanceExpenseLongTerm
1481000
CY2015Q4 agen Debt Instrument Unamortized Discount Long Term
DebtInstrumentUnamortizedDiscountLongTerm
2535000
CY2014Q4 agen Debt Instrument Unamortized Discount Long Term
DebtInstrumentUnamortizedDiscountLongTerm
231000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
114473000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
6026000
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.10
CY2015Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3000000
CY2015Q1 us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P3Y
CY2015 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.102
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
19996000
CY2015Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
34965000
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
54961000
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
5608000
CY2014Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
15279000
CY2014Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
16420000
CY2015Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2015 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.60
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
307000
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
307000
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2015Q4 us-gaap Noncurrent Assets
NoncurrentAssets
16581000
CY2014Q4 us-gaap Noncurrent Assets
NoncurrentAssets
7213000
CY2015Q1 us-gaap Revenues
Revenues
3953000
CY2015Q2 us-gaap Revenues
Revenues
6377000
CY2015Q3 us-gaap Revenues
Revenues
6848000
CY2015Q4 us-gaap Revenues
Revenues
7639000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-18741000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-40410000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-13122000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-15607000
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18792000
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40461000
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13173000
CY2015Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15658000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2014Q1 us-gaap Revenues
Revenues
721000
CY2014Q2 us-gaap Revenues
Revenues
3074000
CY2014Q3 us-gaap Revenues
Revenues
1563000
CY2014Q4 us-gaap Revenues
Revenues
1619000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-357000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-8042000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-8109000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-25978000
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-409000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8091000
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8161000
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26029000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41

Files In Submission

Name View Source Status
0001564590-16-014840-index-headers.html Edgar Link pending
0001564590-16-014840-index.html Edgar Link pending
0001564590-16-014840.txt Edgar Link pending
0001564590-16-014840-xbrl.zip Edgar Link pending
agen-10k_20151231.htm Edgar Link pending
agen-20151231.xml Edgar Link completed
agen-20151231.xsd Edgar Link pending
agen-20151231_cal.xml Edgar Link unprocessable
agen-20151231_def.xml Edgar Link unprocessable
agen-20151231_lab.xml Edgar Link unprocessable
agen-20151231_pre.xml Edgar Link unprocessable
agen-ex1024_396.htm Edgar Link pending
agen-ex1025_395.htm Edgar Link pending
agen-ex211_394.htm Edgar Link pending
agen-ex231_492.htm Edgar Link pending
agen-ex311_378.htm Edgar Link pending
agen-ex312_377.htm Edgar Link pending
agen-ex321_376.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2016031515320355613325.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending